Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

Stefania La Grutta; Franco Frati; Stefania La Grutta; Laura Sensi; Giovanbattista Pajno; Cristoforo Incorvaia; Francesco Marcucci; Alessandro Fiocchi; Francesco Pezzuto

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

Stefania La Grutta, Franco Frati, Stefania La Grutta, Laura Sensi, Giovanbattista Pajno, Cristoforo Incorvaia, Francesco Marcucci, Alessandro Fiocchi, Francesco Pezzuto

Risultato della ricerca: Article › peer review

119 Citazioni (Scopus)

Abstract

The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.

Lingua originale	English
pagine (da-a)	254-258
Numero di pagine	5
Rivista	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
Volume	95
Stato di pubblicazione	Published - 2005

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2723???
???subjectarea.asjc.2400.2403???
???subjectarea.asjc.2700.2740???

Altri file e collegamenti

OA Link

Cita questo

@article{2c9af8bec5ed4d0e9f784bc6248a3fb3,

title = "Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years",

abstract = "The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.",

author = "{La Grutta}, Stefania and Franco Frati and {La Grutta}, Stefania and Laura Sensi and Giovanbattista Pajno and Cristoforo Incorvaia and Francesco Marcucci and Alessandro Fiocchi and Francesco Pezzuto",

year = "2005",

language = "English",

volume = "95",

pages = "254--258",

journal = "ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY",

issn = "1081-1206",

}

TY - JOUR

T1 - Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

AU - La Grutta, Stefania

AU - Frati, Franco

AU - La Grutta, Stefania

AU - Sensi, Laura

AU - Pajno, Giovanbattista

AU - Incorvaia, Cristoforo

AU - Marcucci, Francesco

AU - Fiocchi, Alessandro

AU - Pezzuto, Francesco

PY - 2005

Y1 - 2005

N2 - The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.

AB - The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.

UR - http://hdl.handle.net/10447/102893

M3 - Article

SN - 1081-1206

VL - 95

SP - 254

EP - 258

JO - ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

JF - ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

ER -

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo